0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parkinson’s Disease Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-10O13828
Home | Market Reports | Health| Health Foundations & Medical Research
Global Parkinson s Disease Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Parkinson’s Disease Therapeutics Market Research Report 2024

Code: QYRE-Auto-10O13828
Report
January 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Parkinson’s Disease Therapeutics Market Size

The global Parkinson’s Disease Therapeutics market was valued at US$ 2337.8 million in 2023 and is anticipated to reach US$ 3533.7 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

Parkinson’s Disease Therapeutics Market

Parkinson’s Disease Therapeutics Market

Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
This report aims to provide a comprehensive presentation of the global market for Parkinson’s Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson’s Disease Therapeutics.

Report Scope

The Parkinson’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parkinson’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Parkinson’s Disease Therapeutics Market Report

Report Metric Details
Report Name Parkinson’s Disease Therapeutics Market
Accounted market size in 2023 US$ 2337.8 million
Forecasted market size in 2030 US$ 3533.7 million
CAGR 6.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Parkinson’s Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinson’s Disease Therapeutics Market growing?

Ans: The Parkinson’s Disease Therapeutics Market witnessing a CAGR of 6.0% during the forecast period 2024-2030.

What is the Parkinson’s Disease Therapeutics Market size in 2030?

Ans: The Parkinson’s Disease Therapeutics Market size in 2030 will be US$ 3533.7 million.

Who are the main players in the Parkinson’s Disease Therapeutics Market report?

Ans: The main players in the Parkinson’s Disease Therapeutics Market are Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals

What are the Application segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Applications covered in the Parkinson’s Disease Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Types covered in the Parkinson’s Disease Therapeutics Market report are Oral, Transdermal, Subcutaneous, Intestinal Infusion

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2019-2030)
2.2 Parkinson’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parkinson’s Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Parkinson’s Disease Therapeutics Market Dynamics
2.3.1 Parkinson’s Disease Therapeutics Industry Trends
2.3.2 Parkinson’s Disease Therapeutics Market Drivers
2.3.3 Parkinson’s Disease Therapeutics Market Challenges
2.3.4 Parkinson’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Therapeutics Revenue
3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2023
3.5 Parkinson’s Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Parkinson’s Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parkinson’s Disease Therapeutics Market Size (2019-2030)
6.2 North America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson’s Disease Therapeutics Market Size (2019-2030)
7.2 Europe Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson’s Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction
11.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.1.5 Abbvie Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Parkinson’s Disease Therapeutics Introduction
11.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.2.5 Biogen Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Detail
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hoffman-La Roche
11.4.1 F. Hoffman-La Roche Company Detail
11.4.2 F. Hoffman-La Roche Business Overview
11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction
11.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.4.5 F. Hoffman-La Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 H. Lundbeck A/S
11.6.1 H. Lundbeck A/S Company Detail
11.6.2 H. Lundbeck A/S Business Overview
11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction
11.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.6.5 H. Lundbeck A/S Recent Development
11.7 Impax Labs
11.7.1 Impax Labs Company Detail
11.7.2 Impax Labs Business Overview
11.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction
11.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.7.5 Impax Labs Recent Development
11.8 Newron Pharmaceuticals SpA
11.8.1 Newron Pharmaceuticals SpA Company Detail
11.8.2 Newron Pharmaceuticals SpA Business Overview
11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction
11.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.8.5 Newron Pharmaceuticals SpA Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction
11.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.9.5 Novartis AG Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Detail
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction
11.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.10.5 Orion Corporation Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.12 UCB S.A.
11.12.1 UCB S.A. Company Detail
11.12.2 UCB S.A. Business Overview
11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction
11.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.12.5 UCB S.A. Recent Development
11.13 Livzon Pharmaceutical
11.13.1 Livzon Pharmaceutical Company Detail
11.13.2 Livzon Pharmaceutical Business Overview
11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.13.4 Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.13.5 Livzon Pharmaceutical Recent Development
11.14 Haisco Pharmaceutical
11.14.1 Haisco Pharmaceutical Company Detail
11.14.2 Haisco Pharmaceutical Business Overview
11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.14.4 Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.14.5 Haisco Pharmaceutical Recent Development
11.15 Jingxin Pharmaceutical
11.15.1 Jingxin Pharmaceutical Company Detail
11.15.2 Jingxin Pharmaceutical Business Overview
11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.15.4 Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.15.5 Jingxin Pharmaceutical Recent Development
11.16 Dongcheng Biochemicals
11.16.1 Dongcheng Biochemicals Company Detail
11.16.2 Dongcheng Biochemicals Business Overview
11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Introduction
11.16.4 Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)
11.16.5 Dongcheng Biochemicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Transdermal
    Table 4. Key Players of Subcutaneous
    Table 5. Key Players of Intestinal Infusion
    Table 6. Global Parkinson’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Parkinson’s Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Parkinson’s Disease Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Parkinson’s Disease Therapeutics Market Share by Region (2025-2030)
    Table 12. Parkinson’s Disease Therapeutics Market Trends
    Table 13. Parkinson’s Disease Therapeutics Market Drivers
    Table 14. Parkinson’s Disease Therapeutics Market Challenges
    Table 15. Parkinson’s Disease Therapeutics Market Restraints
    Table 16. Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Parkinson’s Disease Therapeutics Market Share by Players (2019-2024)
    Table 18. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
    Table 19. Ranking of Global Top Parkinson’s Disease Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Parkinson’s Disease Therapeutics Product Solution and Service
    Table 23. Date of Enter into Parkinson’s Disease Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2019-2024)
    Table 31. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2025-2030)
    Table 33. North America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Parkinson’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Abbvie Company Detail
    Table 49. Abbvie Business Overview
    Table 50. Abbvie Parkinson’s Disease Therapeutics Product
    Table 51. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 52. Abbvie Recent Development
    Table 53. Biogen Company Detail
    Table 54. Biogen Business Overview
    Table 55. Biogen Parkinson’s Disease Therapeutics Product
    Table 56. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 57. Biogen Recent Development
    Table 58. Boehringer Ingelheim GmbH Company Detail
    Table 59. Boehringer Ingelheim GmbH Business Overview
    Table 60. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product
    Table 61. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 62. Boehringer Ingelheim GmbH Recent Development
    Table 63. F. Hoffman-La Roche Company Detail
    Table 64. F. Hoffman-La Roche Business Overview
    Table 65. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product
    Table 66. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. F. Hoffman-La Roche Recent Development
    Table 68. GlaxoSmithKline Company Detail
    Table 69. GlaxoSmithKline Business Overview
    Table 70. GlaxoSmithKline Parkinson’s Disease Therapeutics Product
    Table 71. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. GlaxoSmithKline Recent Development
    Table 73. H. Lundbeck A/S Company Detail
    Table 74. H. Lundbeck A/S Business Overview
    Table 75. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product
    Table 76. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. H. Lundbeck A/S Recent Development
    Table 78. Impax Labs Company Detail
    Table 79. Impax Labs Business Overview
    Table 80. Impax Labs Parkinson’s Disease Therapeutics Product
    Table 81. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Impax Labs Recent Development
    Table 83. Newron Pharmaceuticals SpA Company Detail
    Table 84. Newron Pharmaceuticals SpA Business Overview
    Table 85. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product
    Table 86. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Newron Pharmaceuticals SpA Recent Development
    Table 88. Novartis AG Company Detail
    Table 89. Novartis AG Business Overview
    Table 90. Novartis AG Parkinson’s Disease Therapeutics Product
    Table 91. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. Novartis AG Recent Development
    Table 93. Orion Corporation Company Detail
    Table 94. Orion Corporation Business Overview
    Table 95. Orion Corporation Parkinson’s Disease Therapeutics Product
    Table 96. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Orion Corporation Recent Development
    Table 98. Teva Pharmaceutical Industries Ltd. Company Detail
    Table 99. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 100. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product
    Table 101. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 103. UCB S.A. Company Detail
    Table 104. UCB S.A. Business Overview
    Table 105. UCB S.A. Parkinson’s Disease Therapeutics Product
    Table 106. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. UCB S.A. Recent Development
    Table 108. Livzon Pharmaceutical Company Detail
    Table 109. Livzon Pharmaceutical Business Overview
    Table 110. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 111. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 112. Livzon Pharmaceutical Recent Development
    Table 113. Haisco Pharmaceutical Company Detail
    Table 114. Haisco Pharmaceutical Business Overview
    Table 115. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 116. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 117. Haisco Pharmaceutical Recent Development
    Table 118. Jingxin Pharmaceutical Company Detail
    Table 119. Jingxin Pharmaceutical Business Overview
    Table 120. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 121. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 122. Jingxin Pharmaceutical Recent Development
    Table 123. Dongcheng Biochemicals Company Detail
    Table 124. Dongcheng Biochemicals Business Overview
    Table 125. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product
    Table 126. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 127. Dongcheng Biochemicals Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson’s Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Parkinson’s Disease Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Transdermal Features
    Figure 5. Subcutaneous Features
    Figure 6. Intestinal Infusion Features
    Figure 7. Global Parkinson’s Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Parkinson’s Disease Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Parkinson’s Disease Therapeutics Report Years Considered
    Figure 13. Global Parkinson’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Parkinson’s Disease Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Parkinson’s Disease Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
    Figure 19. North America Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)
    Figure 21. United States Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)
    Figure 25. Germany Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Parkinson’s Disease Therapeutics Market Share by Region (2019-2030)
    Figure 33. China Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)
    Figure 41. Mexico Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)
    Figure 45. Turkey Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 48. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 50. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 52. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 53. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 54. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 55. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 56. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 58. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 59. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 60. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 61. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 62. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS